Tenascin‐C and SF/HGF produced by myofibroblasts in vitro provide convergent proinvasive signals to human colon cancer cells through RhoA and Rac
The DOI matches its Crossref record; 62 of the 62 references it cites were found in a registry or an index.
Abstract
Myofibroblasts are present at the invasion front in colon cancer. In an attempt to understand their putative proinvasive activity, we have developed an in vitro model. Myofibroblasts isolated from colon cancer tissue or obtained through transdifferentiation of colon fibroblasts by transforming growth factor (TGF)‐β stimulate invasion of colon cancer cells into collagen type I and Matrigel. We identified two convergent proinvasive agents secreted by myofibroblasts: namely scatter factor/hepatocyte growth factor (SF/HGF) and the TGF‐β‐upregulated extracellular matrix glycoprotein tenascin‐C (TNC), each of which is necessary though not sufficient for invasion. Myofibroblast‐stimulated invasion into collagen type I is characterized by a change from a round, nonmigratory morphotype with high RhoA and low Rac activity to an elongated, migratory morphotype with low RhoA and high Rac activity. RhoA inactivation is determined by the epidermal growth factor (EGF)‐like repeats of TNC through EGF‐receptor signaling that confers a permissive and priming signal for the proinvasive activity of SF/HGF that activates Rac via c‐Met. We confirmed the validity of this mechanism by using pharmacological modulators and dominant negative or constitutive active mutants that interfere with RhoA‐Rho kinase and Rac signaling. Our in vitro results point to a new putative proinvasive signal for colon cancer cells provided by myofibroblasts in the tumor stroma.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Well-established activating signals for fibroblasts include TGFβ family ligands and the lipid mediator lysophosphatidic acid52–54, which promote the activity of the SMAD transcription factors and serum response factor (SRF), respectively, and converge to drive expression of the activated fibroblast marker αSMA as well as increase the activity of the contractile cytoskeleton6”
From A framework for advancing our understanding of cancer-associated fibroblasts (2020) · cites this paper as [52]
In the citing paper
“The production of TGFβ, leukaemia inhibitory factor (LIF), growth arrest-specific protein 6 (GAS6), fibroblast growth factor 5 (FGF5), growth differentiation factor 15 (GDF15) and hepatocyte growth factor (HGF) promotes invasive and proliferative behaviour in cancer cells52,109–112.”
From A framework for advancing our understanding of cancer-associated fibroblasts (2020) · cites this paper as [52]
Citations
Cites
TGF-β Signaling in Tumor Suppression and Cancer Progression
Derynck, R., Akhurst, R. J., & Balmain, A. (2001) · Nature Genetics · doi:10.1038/ng1001-117 · Cited by 2,275
Desmoulière, A., Geinoz, A., Gabbiani, F., & Gabbiani, G. (1993) · The Journal of cell biology · doi:10.1083/jcb.122.1.103 · Cited by 2,243
Regulation of the small GTP-binding protein Rho by cell adhesion and the cytoskeleton
Ren, X.-D. (1999) · The EMBO Journal · doi:10.1093/emboj/18.3.578 · Cited by 1,567
E-cadherin-mediated cell-cell adhesion prevents invasiveness of human carcinoma cells.
Frixen, U. H., Behrens, J., Sachs, M., Eberle, G., Voss, B., Warda, A., Löchner, D., & Birchmeier, W. (1991) · The Journal of cell biology · doi:10.1083/jcb.113.1.173 · Cited by 1,551
Rho GTPases Control Polarity, Protrusion, and Adhesion during Cell Movement
Nobes, C. D., & Hall, A. (1999) · The Journal of Cell Biology · doi:10.1083/jcb.144.6.1235 · Cited by 1,445
Compensation mechanism in tumor cell migration
Wolf, K., Mazo, I., Leung, H., Engelke, K., von Andrian, U. H., Deryugina, E. I., Strongin, A. Y., Bröcker, E.-B., & Friedl, P. (2003) · The Journal of Cell Biology · doi:10.1083/jcb.200209006 · Cited by 1,391
Hypoxia promotes invasive growth by transcriptional activation of the met protooncogene
Pennacchietti, S., Michieli, P., Galluzzo, M., Mazzone, M., Giordano, S., & Comoglio, P. M. (2003) · Cancer Cell · doi:10.1016/s1535-6108(03)00085-0 · Cited by 1,311
Sahai, E., & Marshall, C. J. (2003) · Nature Cell Biology · doi:10.1038/ncb1019 · Cited by 1,147
Role of tissue stroma in cancer cell invasion
De Wever, O., & Mareel, M. (2003) · The Journal of Pathology · doi:10.1002/path.1398 · Cited by 1,042 · cited 2×
“Clinically, myofibroblasts have been associated with invasive cancer (1, 46, 47) and the presently described proinvasive molecules TNC and SF/HGF are found in such cancers.”
BackgroundSelf-citationRac Downregulates Rho Activity
Sander, E. E., ten Klooster, J. P., van Delft, S., van der Kammen, R. A., & Collard, J. G. (1999) · The Journal of Cell Biology · doi:10.1083/jcb.147.5.1009 · Cited by 831
Scatter-factor and semaphorin receptors: cell signalling for invasive growth
Trusolino, L., & Comoglio, P. M. (2002) · Nature Reviews Cancer · doi:10.1038/nrc779 · Cited by 745
Ras and TGFβ cooperatively regulate epithelial cell plasticity and metastasis
Janda, E., Lehmann, K., Killisch, I., Jechlinger, M., Herzig, M., Downward, J., Beug, H., & Grünert, S. (2002) · The Journal of Cell Biology · doi:10.1083/jcb.200109037 · Cited by 706
Regulation of Scatter Factor/Hepatocyte Growth Factor Responses by Ras, Rac, and Rho in MDCK Cells
Ridley, A. J., Comoglio, P. M., & Hall, A. (1995) · Molecular and Cellular Biology · doi:10.1128/mcb.15.2.1110 · Cited by 535
Regulation and Functions of Rho-Associated Kinase
Amano, M., Fukata, Y., & Kaibuchi, K. (2000) · Experimental Cell Research · doi:10.1006/excr.2000.5046 · Cited by 518
Rønnov‐Jessen, L., & Petersen, O. W. (1993) · PubMed · Cited by 513
The de-adhesive activity of matricellular proteins: is intermediate cell adhesion an adaptive state?
Murphy-Ullrich, J. E. (2001) · Journal of Clinical Investigation · doi:10.1172/jci12609 · Cited by 476
A Signaling Adapter Function for α6β4 Integrin in the Control of HGF-Dependent Invasive Growth
Trusolino, L., Bertotti, A., & Comoglio, P. M. (2001) · Cell · doi:10.1016/s0092-8674(01)00567-0 · Cited by 420
Sayan, B. S. (2004) · Cell Death & Differentiation · doi:10.1038/sj.cdd.4401459 · Cited by 388
Metastasis is driven by sequential elevation of H-ras and Smad2 levels
Oft, M., Akhurst, R. J., & Balmain, A. (2002) · Nature Cell Biology · doi:10.1038/ncb807 · Cited by 373
Kuper, H., Τζώνου, Α., Kaklamani, E., Hsieh, C., Λάγιου, Π., Adami, H., Trichopoulos, D., & Stuver, S. O. (2000) · International Journal of Cancer · doi:10.1002/(sici)1097-0215(20000215)85:4<503::aid-ijc10>3.0.co;2-l · Cited by 356
Epidermal growth factor (EGF)-like repeats of human tenascin-C as ligands for EGF receptor
Swindle, C. S., Tran, K. T., Johnson, T. D., Banerjee, P., Mayes, A. M., Griffith, L., & Wells, A. (2001) · The Journal of Cell Biology · doi:10.1083/jcb.200103103 · Cited by 286
Royal, I., Lamarche-Vane, N., Lamorte, L., Kaibuchi, K., & Park, M. (2000) · Molecular Biology of the Cell · doi:10.1091/mbc.11.5.1709 · Cited by 277
Attoub, S., Noe, V., Pirola, L., Bruyneel, E., Chastre, E., Mareel, M., Wymann, M. P., & Gespach, C. (2000) · The FASEB Journal · doi:10.1096/fj.00-0162 · Cited by 235
Self-citationN-Cadherin Promotes Adhesion Between Invasive Breast Cancer Cells and the Stroma
Hazan, R. B., Kang, L., Whooley, B. P., & Borgen, P. I. (1997) · Cell Adhesion and Communication · doi:10.3109/15419069709004457 · Cited by 231
Santos, O. F. P., & Nigam, S. K. (1993) · Developmental Biology · doi:10.1006/dbio.1993.1308 · Cited by 210
Clinical impact and functional aspects of tenascin‐C expression during glioma progression
Herold‐Mende, C., Mueller, M. M., Bonsanto, M. M., Schmitt, H. P., Kunze, S., & Steiner, H. (2002) · International Journal of Cancer · doi:10.1002/ijc.10233 · Cited by 169
Out of air is not out of action
Bottaro, D. P., & Liotta, L. A. (2003) · Nature · doi:10.1038/423593a · Cited by 168
Neaud, V, Faouzi, S., Guirouilh, J., Le Bail, B., Balabaud, C., Bioulac-Sage, P., & Rosenbaum, J. (1997) · Hepatology · doi:10.1002/hep.510260612 · Cited by 167
Vermeulen, S. J. T., Bruyneel, E. A., Bracke, M., Bruyne, G. K. D., Vennekens, K. M., Vleminckx, K., Berx, G., Roy, F. M. V., & Mareel, M. (1995) · PubMed · Cited by 166
Self-citationSiri, A., Knäuper, V., Veirana, N., Caocci, F., Murphy, G., & Zardi, L. (1995) · Journal of Biological Chemistry · doi:10.1074/jbc.270.15.8650 · Cited by 165
Liu, C., Park, M., & Tsao, M. (1992) · PubMed · Cited by 155
Chiquet‐Ehrismann, R., Kalla, P., & Pearson, C. A. (1989) · PubMed · Cited by 148
Neaud, V. (1997) · Hepatology · doi:10.1053/jhep.1997.v26.pm0009397985 · Cited by 146
Epimorphin Functions as a Key Morphoregulator for Mammary Epithelial Cells
Hirai, Y., Lochter, A., Galosy, S., Koshida, S., Niwa, S., & Bissell, M. J. (1998) · The Journal of Cell Biology · doi:10.1083/jcb.140.1.159 · Cited by 141
Paraskeva, C., Buckle, B. G., Sheer, D., & Wigley, C. B. (1984) · International Journal of Cancer · doi:10.1002/ijc.2910340109 · Cited by 138
Owen, J. D., Strieter, R., Burdick, M., Haghnegahdar, H., Nanney, L., Shattuck-Brandt, R., & Richmond, A. (1997) · International Journal of Cancer · doi:10.1002/(sici)1097-0215(19970926)73:1<94::aid-ijc15>3.0.co;2-5 · Cited by 133
Kodama, A., Matozaki, T., Fukuhara, A., Kikyo, M., Ichihashi, M., & Takai, Y. (2000) · Molecular Biology of the Cell · doi:10.1091/mbc.11.8.2565 · Cited by 126
Tenascin-C Suppresses Rho Activation
Wenk, M. B., Midwood, K. S., & Schwarzbauer, J. E. (2000) · The Journal of Cell Biology · doi:10.1083/jcb.150.4.913 · Cited by 123
Dimanche‐Boitrel, M. T., Vakaet, L., Pujuguet, P., Chauffert, B., Martin, M. S., Hammann, A., Van Roy, F., Mareel, M., & Martin, F. (1994) · International Journal of Cancer · doi:10.1002/ijc.2910560410 · Cited by 119
Self-citationHanamura, N., Yoshida, T., Matsumoto, E.-I., Kawarada, Y., & Sakakura, T. (1997) · International Journal of Cancer · doi:10.1002/(sici)1097-0215(19970926)73:1<10::aid-ijc2>3.0.co;2-4 · Cited by 118
Emami, S., Floch, N. L., Bruyneel, E. A., Thim, L., May, F. E. B., Westley, B. R., Rio, M., Mareel, M. M. K., & Gespach, C. P. (2001) · The FASEB Journal · doi:10.1096/fj.00-0355com · Cited by 114
Self-citationSerum hepatocyte growth factor as an index of disease status of patients with colorectal carcinoma
Fukuura, T., Miki, C., Inoue, T., Matsumoto, K., & Suzuki, H. (1998) · British Journal of Cancer · doi:10.1038/bjc.1998.514 · Cited by 87
Parr, C., Hiscox, S., Nakamura, T., Matsumoto, K., & Jiang, W. G. (2000) · International Journal of Cancer · doi:10.1002/(sici)1097-0215(20000215)85:4<563::aid-ijc19>3.0.co;2-d · Cited by 80
Corneal wound healing in tenascin knockout mouse.
Matsuda, A., Yoshiki, A., Tagawa, Y., Matsuda, H., & Kusakabe, M. (1999) · PubMed · Cited by 76
Rodrigues-Ferreira, S., Attoub, S., Nguyen, Q., Bruyneel, E. A., Rodrigue, C. M., Westley, B. R., May, F. E. B., Thim, L., Mareel, M., Emami, S., et al. (2003) · Oncogene · doi:10.1038/sj.onc.1206685 · Cited by 74
Self-citationQian, L.-W., Mizumoto, K., Maehara, N., Ohuchida, K., Inadome, N., Saimura, M., Nagai, E., Matsumoto, K., Nakamura, T., & Tanaka, M. (2003) · Cancer Letters · doi:10.1016/s0304-3835(02)00517-7 · Cited by 73
Tang, R., Wang, J., Lo, S. K., & Hsieh, L. (1999) · International Journal of Cancer · doi:10.1002/(sici)1097-0215(19990812)82:4<473::aid-ijc1>3.0.co;2-k · Cited by 70
Altered content and distribution of tenascin in colitis, colon adenoma, and colorectal carcinoma
Riedl, S., Faissner, A., Schlag, P., Herbay, A. V., Koretz, K., & Möller, P. (1992) · Gastroenterology · doi:10.1016/0016-5085(92)90827-l · Cited by 58
Dueck, M., Riedl, S., Hinz, U., Tandara, A., M�ller, P., Herfarth, C., & Faissner, A. (1999) · International Journal of Cancer · doi:10.1002/(sici)1097-0215(19990812)82:4<477::aid-ijc2>3.0.co;2-5 · Cited by 57
Nguyen, Q.-D., Faivre, S., Bruyneel, E., Rivat, C., Seto, M., Endo, T., Mareel, M., Emami, S., & Gespach, C. (2002) · The FASEB Journal · doi:10.1096/fj.01-0525com · Cited by 55
Self-citationThe Role of Myofibroblasts at the Tumor Border of Invasive Colorectal Adenocarcinomas
Nakayama, H., Enzan, H., Miyazaki, E., Naruse, K., Kiyoku, H., & Hiroi, M. (1998) · Japanese Journal of Clinical Oncology · doi:10.1093/jjco/28.10.615 · Cited by 49
Empereur, S., Djelloul, S., Di Gioia, Y., Bruyneel, E., Mareel, M., Van Hengel, J., Van Roy, F., Comoglio, P., Courtneidge, S., Paraskeva, C., et al. (1997) · British Journal of Cancer · doi:10.1038/bjc.1997.40 · Cited by 49
Self-citationYoshida, S., Harada, T., Iwabe, T., Taniguchi, F., Fujii, A., Sakamoto, Y., Yamauchi, N., Shiota, G., & Terakawa, N. (2002) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.87.5.8483 · Cited by 48
Bracke, M., Boterberg, T., Bruyneel, E. A., & Mareel, M. M. K. (2003) · Humana Press eBooks · doi:10.1385/1-59259-137-x:081 · Cited by 45
Self-citationWeakening link to colorectal cancer?
Barbier, M., Attoub, S., Calvez, R., Laffargue, M., Jarry, A., Mareel, M., Altruda, F., Gespach, C. P., Wu, D. W., Lu, B., et al. (2001) · Nature · doi:10.1038/35101660 · Cited by 45
Self-citationMiura, S., Kodaira, S., & Hosoda, Y. (1993) · Journal of Surgical Oncology · doi:10.1002/jso.2930530111 · Cited by 41
Vermeulen, S., Bruyneel, E. A., Bracke, M., Bruyne, G. D., Vennekens, K. M., Vleminckx, K., Berx, G., van Roy, F., & Mareel, M. (1995) · Ghent University Academic Bibliography (Ghent University) · Cited by 39
Self-citationThe N-Cadherin/Catenin Complex in Colon Fibroblasts and Myofibroblasts
Hoorde, L. V., Braet, K., & Mareel, M. (1999) · Cell Communication & Adhesion · doi:10.3109/15419069909034397 · Cited by 29
Self-citationβ‐casein‐derived peptides, produced by bacteria, stimulate cancer cell invasion and motility
Oliveira, M. J., Damme, J. V., Lauwaet, T., Corte, V. D., Bruyne, G. D., Verschraegen, G., Vaneechoutte, M., Goethals, M., Ahmadian, M. R., Müller, O., et al. (2003) · The EMBO Journal · doi:10.1093/emboj/cdg586 · Cited by 25
Self-citationIn Vitro Invasion Assay Using Matrigel®
Hall, D. M. S., & Brooks, S. A. (2003) · Humana Press eBooks · doi:10.1385/1-59259-137-x:061 · Cited by 24
de Vries, J. E., Kornips, F. H. A. C., Marx, P., Bosman, F. T., Geraedts, J. P. M., & ten Kate, J. (1993) · Cancer Genetics and Cytogenetics · doi:10.1016/0165-4608(93)90041-j · Cited by 20
Islam, M. Q., Köpf, I., LEVAN, A., Granberg, S., Friberg, L., & Levan, G. (1993) · Cancer Genetics and Cytogenetics · doi:10.1016/0165-4608(93)90056-r · Cited by 14
Research works printed but not linked: 2
- Bracke M. E., 2001, Methods in Molecular Medicine, 81
- 10.1210/jc.87.5.2376 · doi:10.1210/jc.87.5.2376
Cited by
A framework for advancing our understanding of cancer-associated fibroblasts
Sahai, E., Astsaturov, I., Cukierman, E., DeNardo, D. G., Egeblad, M., Evans, R. M., Fearon, D., Greten, F. R., Hingorani, S. R., Hunter, T., et al. (2020) · Nature Reviews Cancer · doi:10.1038/s41568-019-0238-1 · Cited by 3,863
Friends or foes — bipolar effects of the tumour stroma in cancer
Mueller, M. M., & Fusenig, N. E. (2004) · Nature Reviews Cancer · doi:10.1038/nrc1477 · Cited by 1,765
Formation and function of the myofibroblast during tissue repair
Hinz, B. (2007) · Journal of Investigative Dermatology · doi:10.1038/sj.jid.5700613 · Cited by 1,658
“Tenascin-C appears to attract fibroblasts and to promote their differentiation into myofibroblast in injured tissue (Tamaoki et al., 2005) and at the tumor invasion front of cancers (De Wever et al., 2004).”
BackgroundGaggioli, C., Hooper, S., Hidalgo-Carcedo, C., Grosse, R., Marshall, J. F., Harrington, K., & Sahai, E. (2007) · Nature Cell Biology · doi:10.1038/ncb1658 · Cited by 1,589
Integrins as biomechanical sensors of the microenvironment
Kechagia, J. Z., Ivaska, J., & Roca-Cusachs, P. (2019) · Nature Reviews Molecular Cell Biology · doi:10.1038/s41580-019-0134-2 · Cited by 1,311
Metadata
- Authors
- De Wever, O., Nguyen, Q., Van Hoorde, L., Bracke, M., Bruyneel, E., Gespach, C., & Mareel, M.
- Affiliations
- Laboratory of Experimental Cancerology, Department of Radiotherapy and Nuclear Medicine Ghent University Hospital B‐9000 Gent Belgium
- Inserm (FR)
- Ghent University Hospital (BE)
- Venue
- The FASEB Journal
- Publisher
- Wiley
- Published
- 2004-04
- Volume
- 18
- Issue
- 9
- Pages
- 1016-1018
- ISSN
- 0892-6638 (ISSN-L)
- 1530-6860
- OpenAlex
- W2135114065
- Cited by
- 402
- References
- 58
- Citations by year
- 2026: 5 · 2025: 7 · 2024: 7 · 2023: 21 · 2022: 16 · 2021: 14 · 2020: 19 · 2019: 16 · 2018: 21 · 2017: 24 · 2016: 20 · 2015: 16 · 2014: 25 · 2013: 23 · 2012: 19
- FWCI
- 5.45
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- The FASEB Journal (publishedVersion)
- PubMed (publishedVersion)
- Ghent University Academic Bibliography (Ghent University) (submittedVersion)
- Funders
- Kom op tegen Kanker
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Protein Kinase Regulation and GTPase Signaling
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › TGF-β signaling in diseases
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Mechanisms of cancer metastasis
- Keywords
- tenascin-C, myofibroblasts, colon cancer, tumor invasion, RhoA, Rac, Rho kinase, c-Met, EGF-like repeats, EGF receptor signaling, tumor stroma, TGF-beta, type I collagen, cell migration, tumor microenvironment
- MeSH terms
- Cell Differentiation, Collagen, Colonic Neoplasms, Dose-Response Relationship, Drug, Drug Combinations, Enzyme Activation, Fibroblasts, Humans, Laminin, Neoplasm Invasiveness, Proteoglycans, Solubility, Transforming Growth Factor beta, Hepatocyte Growth Factor, Protein Serine-Threonine Kinases, Tenascin, Cell Lineage, rhoA GTP-Binding Protein, rac GTP-Binding Proteins, Muscle Cells, Cell Line, Tumor, Intracellular Signaling Peptides and Proteins, Transforming Growth Factor beta1, rho-Associated Kinases
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.